Kane Biotech Brings revyve® Wound Care Innovation to Global Stage
Summary: Kane Biotech highlighted its revyve® wound care platform at an international conference, presenting a compelling case study of a high-risk diabetic foot ulcer patient. The technology combines biofilm-disrupting agents with advanced delivery to improve healing in challenging chronic wounds.
Key Highlights:
- Case study focused on complex, high-risk DFU
- Biofilm-targeted approach to support healing
- Presented on global stage for wound care innovation
- Potential new option for difficult-to-heal diabetic foot ulcers
Keywords: revyve wound care, Kane Biotech, biofilm DFU